Archive for the ‘Industry Overview’ Category

SAFC Prepares for ESACT 2013

Tuesday, June 18th, 2013

Join SAFC for the 23rd annual ESACT Meeting taking place in Lille, France from June 23rd through June 26th at Booth # A3.

ESACT was founded 35 years ago and since then has developed into an international reference event in animal cell technology, building on a tradition of combining both basic science and its application into industrial biotechnology.

SAFC is excited to be the silver sponsor this year. We have an action packed schedule that our team has worked on to offer colleagues with a look into SAFC as part of their ESACT experience. We will kick things off on Sunday, June 23rd from 11:15 – 13:15 p.m. at the Artois Room with a presentation on:

(more…)

SAFC Lives: Dr. Andreas Weiler, Strategic Marketing Manager of Pharma Contract Manufacturing Services

Wednesday, June 12th, 2013
Dr. Andreas Weiler

Dr. Andreas Weiler

SAFC Lives presents personnel profiles where we talk to the people who make SAFC tick to find out more about their personalities, position, what drives them, and what they enjoy doing when they are not playing a critical role in the ongoing growth of SAFC.

In this edition, we talk with Dr. Andreas Weiler, Strategic Marketing Manager of Pharma Contract Manufacturing Services in Buchs, Switzerland.

(more…)

Manufacturing Chemist Magazine Features SAFC President Gilles Cottier

Friday, June 7th, 2013

Gilles Cottier, President of SAFC, was featured in an interview with Hilary Ayshford from Manufacturing Chemist where he shared his journey in the company and his vision as a President.

Gilles spoke to SAFC’s customer intimate approach and how SAFC works to make drugs available and affordable for the global market, enabling a quality life for our future, and picking areas in this vast market where SAFC can play to win.

(more…)

Commercial Licensing of CHOZN® Cell Line in Asia

Tuesday, June 4th, 2013

SAFC is pleased to announce that two leading Asian biopharmaceutical companies have signed commercial sales and licensing contracts for the purchase of their off-the-shelf cell line production platform CHOZN®. The customers have confirmed that they will use the platform as a key component in support from development stage through commercialization.

This acts a step towards gaining greater traction in the Asia Pacific market, which SAFC sees as an important market to align with. The purchases also support SAFC’s drive to further integrate the CHOZN platform in the biopharmaceutical space and help customers to drive innovation.

Please see the full press release below.   (more…)

Webcast: Achieving Supply-Chain Transparency

Friday, May 31st, 2013

SAFC would like to invite you to join us for a complimentary 60-minute webcast hosted with Pharmaceutical Technology on Tuesday, June 18th at 11:00 AM EDT. Esteemed industry colleagues from AbbVie and Axendia will join Tom Beil, VP of Quality and Regulatory Affairs at Sigma-Aldrich, to discuss increasing regulatory demands on drug product suppliers and how to formulate a strategic approach for meeting these demands.

(more…)

Evolving Biopharmaceutical Manufacturing: Genome Editing through Zinc Finger Nuclease Technology

Wednesday, May 29th, 2013

Biopharmaceutical companies are often challenged by the need to create robust, efficient cell lines with the ability to modify, delete, or add heritable genes. Zinc Finger Nuclease (ZFN) technology has proven to offer an answer to this dilemma.

(more…)

Blogging from TIDES

Thursday, May 23rd, 2013

The 15th annual TIDES conference returned to Boston this May 12th to 15th to bring industry colleagues together with a focus on the discovery and manufacturing of oligonucleotide and peptide therapeutics. SAFC enjoyed being onsite at the four-day event, where it was clear that the importance of oligonucleotides is growing in the pharmaceutical industry. There are now more than 100 oligonucleotide drugs in the clinic, and very many more are in the earlier stages of development.

(more…)